SCD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SCD monoclonal antibodies for studying stearoyl-CoA desaturase (SCD). SCD Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Stearoyl-CoA desaturase plays a central role in lipid metabolism by converting saturated fatty acids into monounsaturated fatty acids, which are essential for maintaining membrane fluidity and function. The regulation of stearoyl-CoA desaturase influences various physiological processes, including energy homeostasis, insulin sensitivity, and the development of metabolic disorders. Understanding stearoyl-CoA desaturase function can provide insights into the mechanisms underlying obesity, diabetes, and cardiovascular diseases. Research focused on stearoyl-CoA desaturase has revealed its significance in cellular metabolism and potential therapeutic applications. Investigating stearoyl-CoA desaturase expression patterns helps researchers better understand lipid metabolism disorders. The role of stearoyl-CoA desaturase in disease progression continues to be an active area of scientific investigation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of lipid metabolism and its impact on human health.